常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.76/-0.09
|
|
企业价值
17.89M
|
| 资产负债 |
|
每股账面净值
-0.02
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
4.94M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engagedin designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heartfailure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves. |

0.1821 
